Abstract
With the surgical improvement of congenital heart disease, Fontan operation has been applied to many complicated patients in recent years. This is the first report of a child with panhypopituitarism who underwent Fontan operation. A 5-year-old boy was scheduled for Fontan operation. He previously underwent Blalock-Taussig shunt and bidirectional Glenn operations for univentricular heart with double-outlet right ventricle and pulmonary atresia. He was receiving hydrocortisone and 1-desamino-8-D-arginine vasopressin (DDAVP) for panhypopituitarism secondary to removal of craniopharyngioma performed at the age of three years. Although urine output and serum sodium concentration were adequately controlled by adjustment of vasopressin infusion rate during surgery, massive pleural effusions and ascites developed postoperatively, which required several days for control by adjusting the dose of oral DDAVP and normalize the serum sodium level. Intraoperative management of Fontan operation for a patient with panhypopituitarism was controllable by appropriate hormone replacement. However, postoperative fluid management was complicated by the clinical features of panhypopituitarism and Fontan physiology.
Similar content being viewed by others
References
Triedman JK, Newburger JW. Trends in congenital heart disease. Circulation. 2016;133(25):2716–33.
Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240–8.
Gewillig M, Brown SC. The fontan circulation after 45 years: update in physiology. Heart. 2016;102(14):1081–6.
Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants and children. Best Pract Res Clin Endocrinol Metab. 2016;30(2):317–28.
Yasim A, Oksuz H, Ozkaya M. Open heart surgery in a patient with diabetes insipidus. Interact Cardiovasc Thorac Surg. 2008;7(6):1172–3.
Takagi K, Tayama E. Hormone replacement therapy for open heart surgery in a patient with panhypopituitarism and diabetes insipidus. Interact CardioVasc Thorac Surg. 2020;31(3):413–4.
Higham CE, Johannsson G, Shalet SM. Hypopituitarism. Lancet (London, England). 2016;388(10058):2403–15.
Garrahy A, Sherlock M, Thompson CJ. Neuroendocrine surveillance and management of neurosurgical patients. Eur J Endocrinol. 2017;176(5):217–33.
Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888–921.
Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017;8(3):33–48.
Maxey TS. Fontan Procudure. In: Ungerleider RM, Nelson K, Jacobs JP, Meliones JN, Cooper DS, editors. Critical Heart Disease in Infants and Children. 3rd ed. Newyork: Elsevier; 2019.
Gupta A, Daggett C, Behera S, Ferraro M, Wells W, Starnes V. Risk factors for persistent pleural effusions after the extracardiac Fontan procedure. J Thorac Cardiovasc Surg. 2004;127(6):1664–9.
Kim G, Ko H, Byun JH, Lee HD, Kim H, Sung SC, et al. Risk factors for prolonged pleural effusion after extracardiac fontan operation. Pediatr Cardiol [Internet]. 2019;40(8):1545–52.
Walker SG. Endocrine, Metabolic, and Electrolyte Responses. In: Gravlee GP, Davis RF, Stammers AH, Ungerleider RM, editors. Cardiopulmonary bypass principles and practice. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2007.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sunoki, K., Otsuka, Y., Iwai, H. et al. Perioperative management of Fontan operation for the child with panhypopituitarism: a case report. J Anesth 35, 303–306 (2021). https://doi.org/10.1007/s00540-020-02894-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-020-02894-5